{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T14:58:36Z","timestamp":1758121116029,"version":"3.43.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1023\/a:1015254315839","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T17:49:38Z","timestamp":1041097778000},"page":"207-215","source":"Crossref","is-referenced-by-count":13,"title":["Homocysteine and C-reactive protein levels in Haemodialysis patients"],"prefix":"10.1007","volume":"33","author":[{"given":"E.","family":"Koulouridis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Tzilianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Katsarou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Costimba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Klonou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Panagiotaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Georgalidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Krokida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Delaportas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lachanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Karaliotas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Kaliolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"397674_CR1","first-page":"111","volume":"56","author":"KS. McCully","year":"1969","unstructured":"McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111\u2013128.","journal-title":"Am J Pathol"},{"key":"397674_CR2","first-page":"473","volume":"114","author":"PM Ueland","year":"1989","unstructured":"Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J Lab Clin Med 1989; 114: 473\u2013401.","journal-title":"J Lab Clin Med"},{"key":"397674_CR3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assesment of plasma homocysteine as a risk factor for vascular disease; probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049\u20131057.","journal-title":"JAMA"},{"key":"397674_CR4","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","volume":"334","author":"M Den Heijer","year":"1996","unstructured":"Den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759\u2013762.","journal-title":"N Engl J Med"},{"key":"397674_CR5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willen WC et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877\u2013881.","journal-title":"JAMA"},{"key":"397674_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1997","unstructured":"Nygard O, Nordrehaug JE, Refsum H et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230\u2013236.","journal-title":"N Engl J Med"},{"key":"397674_CR7","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med 1998; 338: 1042\u20131050.","journal-title":"N Engl J Med"},{"key":"397674_CR8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973\u2013979.","journal-title":"N Engl J Med"},{"key":"397674_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.CIR.99.2.237","volume":"99","author":"W Koenig","year":"1999","unstructured":"Koenig W, Sud M, Frohlich M, Fischer H-G et al. C-reactive protein, a sensitive marker of systemic inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA-Augsburg cohort study 1984-92. Circulation 1999; 99: 237\u2013242.","journal-title":"Circulation"},{"key":"397674_CR10","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1093\/ndt\/14.12.2798","volume":"14","author":"W Koenig","year":"1999","unstructured":"Koenig W, Wanner C. C-reactive protein and coronary artery disease - what is the link? Nephrol Dial Transplant 1999; 14: 2798-00.","journal-title":"Nephrol Dial Transplant"},{"key":"397674_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2362.1979.tb00888.x","volume":"9","author":"DE Wilcken","year":"1979","unstructured":"Wilcken DE, Gupta VJ. Sulphur containing amino acids in chronic renal failure with particular reference to homocysteine and cystine-homocysteine mixed disulphid. Eur J Clin Invest 1979; 9: 301\u2013307.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"397674_CR12","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","volume":"97","author":"A Moustapha","year":"1998","unstructured":"Moustapha A, Naso A, Nahlawi M, Gupta A, Arheart KL, Jacobsen DW, Robinson K, Dennis VW. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998 Jan 20; 97(2): 138\u2013141.","journal-title":"Circulation"},{"issue":"4","key":"397674_CR13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0272-6386(99)70392-6","volume":"34","author":"BJ Manns","year":"1999","unstructured":"Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am J Kidney Dis 1999 Oct; 34(4): 669\u2013677.","journal-title":"Am J Kidney Dis"},{"key":"397674_CR14","first-page":"236","volume":"40","author":"M Arnadottir","year":"1993","unstructured":"Arnadottir M, Brattstrom L, Simonsen O et al. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993; 40: 236\u2013240.","journal-title":"Clin Nephrol"},{"key":"397674_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.1996.19","volume":"49","author":"AG Bostom","year":"1996","unstructured":"Bostom AG, Shemin D, Lapane KL et al. High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int. 1996; 49: 147\u2013152.","journal-title":"Kidney Int."},{"key":"397674_CR16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/13.1.106","volume":"13","author":"C Van Guldener","year":"1998","unstructured":"Van Guldener C, Janssen M, Lambert J et al. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinemia in haemodialysis patients. Nephrol Dial Transplant 1998; 13: 106\u2013112.","journal-title":"Nephrol Dial Transplant"},{"key":"397674_CR17","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/ndt\/14.12.2903","volume":"14","author":"P Jungers","year":"1999","unstructured":"Jungers P, Joly D, Massy Ziad et al. Sustained reduction of hyperhomocysteinemia with folic acid supplementation in predialysis patients. Nephrol Dial Transplant 1999; 14: 2903\u20132906.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"397674_CR18","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1046\/j.1523-1755.1999.00792.x","volume":"56","author":"M Touam","year":"1999","unstructured":"Touam M, Zingraff J, Jungers P, Chadefaux-Vekemans B, Drueke T, Massy ZA. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney Int 1999 Dec; 56(6): 2292\u20132296.","journal-title":"Kidney Int"},{"key":"397674_CR19","first-page":"810","volume":"14","author":"ZA. Massy","year":"1999","unstructured":"Massy ZA. Reversal of hyperhomocysteinemia in chronic renal failure is folic or folinic acid the answer? Nephrol Dial Transplant 1999; 14: 2810\u20132812.","journal-title":"Nephrol Dial Transplant"},{"key":"397674_CR20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1681\/ASN.V651329","volume":"6","author":"J Bergstrom","year":"1995","unstructured":"Bergstrom J, Heimburger O, Lindholm B, Qureshi AR. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients. J Am Soc Nephrol 1995; 6: 573 (Abst).","journal-title":"J Am Soc Nephrol"},{"key":"397674_CR21","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/ndt\/14.8.1956","volume":"14","author":"K Iseki","year":"1999","unstructured":"Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956\u20131960.","journal-title":"Nephrol Dial Transplant"},{"key":"397674_CR22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","volume":"55","author":"J Zimmermann","year":"1999","unstructured":"Zimmermann J, Herrlinger S, Pruy A, Metzger T. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648\u2013658.","journal-title":"Kidney Int"},{"key":"397674_CR23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1997.359","volume":"52","author":"AB Guttormsen","year":"1997","unstructured":"Guttormsen AB, Ueland PM, Svarstad E, Refsum H. Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 1997; 52: 495\u2013502.","journal-title":"Kidney Int"},{"key":"397674_CR24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0021-9150(95)05522-X","volume":"116","author":"A Bostom","year":"1995","unstructured":"Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995; 116: 59\u201362.","journal-title":"Atherosclerosis"},{"key":"397674_CR25","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ndt\/15.7.1029","volume":"15","author":"AA House","year":"2000","unstructured":"House AA, Wells GA, Donnely GJ, Nadler SP, Hebert PC. Randomized trial of high-flux haemodialysis: effects on homocysteine and lipids. Nephrol Dial Transplant 2000; 15: 1029\u20131034.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"397674_CR26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00002480-200009000-00023","volume":"46","author":"S Biasoli","year":"2000","unstructured":"Biasoli S, Schiavon R, Petrosino L, Cavallini L, Cavalcanti G, De Fanti E, Zambello A, Borin D. Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia and oxidative stress. ASAIO 2000 Sep; 46(5): 625\u2013634.","journal-title":"ASAIO"},{"issue":"1","key":"397674_CR27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1046\/j.1523-1755.2001.00496.x","volume":"59","author":"A Van Tellingen","year":"2001","unstructured":"Van Tellingen A, Grooteman MP, Bartels PC, Van Limbeek J, Van Guldener C, Wee PM, Nube MJ. Long-term reduction of plasma homocysteine levels by superflux dialyzers in haemodialysis patients. Kidney Int 2001; 59(1): 342\u2013347.","journal-title":"Kidney Int"},{"issue":"6","key":"397674_CR28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s001340050908","volume":"25","author":"MC Fortin","year":"1999","unstructured":"Fortin MC, Amyot SL, Geadah D, Leblanc M. Serum concentrations and clearances of folic acid and pyridoxal-5-phosphate during venovenous continuous renal replacement therapy. Intensive Care Med 1999 Jun; 25(6): 594\u2013598.","journal-title":"Intensive Care Med"},{"issue":"4","key":"397674_CR29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/jren.2000.16327","volume":"10","author":"M Leblanc","year":"2000","unstructured":"Leblanc M, Pichette V, Geadah D, Quimet D. Folic acid and pyridoxal-5'-phosphate losses during high-efficiency haemodialysis in patients without hydrosoluble vitamin supplementation. J Ren Nutr 2000; 10(4): 196\u2013201.","journal-title":"J Ren Nutr"},{"issue":"Suppl2","key":"397674_CR30","first-page":"S23","volume":"2","author":"AL Babb","year":"1975","unstructured":"Babb AL, Strand MJ, Uvelli DA, Scribner BH. Quantitative description of dialysis treatment: a dialysis index. Kidney Int 1975; 2(Suppl 2): S23.","journal-title":"Kidney Int"},{"key":"397674_CR31","first-page":"749","volume-title":"Megaloblastic and non Megaloblastic anemias in Wintrobe's Clinical Hematology","author":"R. G. Lee","year":"1993","unstructured":"Richard Lee G. Megaloblastic and non Megaloblastic anemias in Wintrobe's Clinical Hematology (9th ed). In: G. Richard Lee, Thomas G. Bithell, John Foerster, John w. Athens, John N. Lukens, eds. Philadelphia - London: LEA & FEBIJER, 1993. Vol 1; pp 749-780.","edition":"(9th ed)."},{"key":"397674_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1172\/JCI108932","volume":"61","author":"J Kushner","year":"1978","unstructured":"Kushner J, Broder ML, Karp D. Control of the acute phase response: Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978; 61: 235\u2013242.","journal-title":"J Clin Invest"},{"issue":"Supp76","key":"397674_CR33","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1046\/j.1523-1755.2000.07612.x","volume":"58","author":"V Panichi","year":"2000","unstructured":"Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovani L, Palla R. The link of biocompatibility to cytokine production. Kidney Int 2000; 58 (Supp 76): S96\u2013S103.","journal-title":"Kidney Int"},{"key":"397674_CR34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/ndt\/15.3.379","volume":"15","author":"E Wilhelmina","year":"2000","unstructured":"Wilhelmina E, Schouten M, Muriel P, Grooteman C, Van Houte AJ, Schoorl M, Van Limbeek J, Nube MJ. Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis. Nephrol Dial Transplant 2000; 15: 379\u2013384.","journal-title":"Nephrol Dial Transplant"},{"key":"397674_CR35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1681\/ASN.V72198","volume":"7","author":"CANADA-USA","year":"1996","unstructured":"CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 1996; 7: 198\u2013207.","journal-title":"J Am Soc Nephrol"},{"key":"397674_CR36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1997.298","volume":"52","author":"AG Bostom","year":"1997","unstructured":"Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997; 52: 10\u201320.","journal-title":"Kidney Int"},{"key":"397674_CR37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2362.1979.tb00888.x","volume":"9","author":"DEL Wilcken","year":"1979","unstructured":"Wilcken DEL, Gupta VJ. Sulphur-containing amino acids in chronic renal failure with particular reference to cysteinehomocysteine mixed disulfide. Eur J Clin Invest 1979; 9: 301\u2013307.","journal-title":"Eur J Clin Invest"},{"key":"397674_CR38","first-page":"230","volume":"40","author":"B Hultberg","year":"1993","unstructured":"Hultberg B, Anderson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40: 230\u2013234.","journal-title":"Clin Nephrol"},{"key":"397674_CR39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0021-9150(96)05809-1","volume":"123","author":"AG Bostom","year":"1996","unstructured":"Bostom AG, Shemin D, Lapane KL et al. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 1996; 123: 193\u2013202.","journal-title":"Atherosclerosis"},{"issue":"4","key":"397674_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0272-6386(97)90339-5","volume":"29","author":"P Barany","year":"1997","unstructured":"Barany P, Filho JCD, Bergstrom J. High C-reactive protein is a strong predictor of resistance to erythropoietin in haemodialysis patients. Am J Kidney Dis 1997; 29(4): 565\u2013568.","journal-title":"Am J Kidney Dis"},{"key":"397674_CR41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1755.1998.00032.x","volume":"54","author":"WF Owen","year":"1998","unstructured":"Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance haemodialysis patients. Kidney Int 1998; 54: 627\u2013636.","journal-title":"Kidney Int"},{"issue":"1","key":"397674_CR42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0272-6386(99)70259-3","volume":"33","author":"J Gunnell","year":"1999","unstructured":"Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in haemodialysis and peritoneal dialysis patients. Am J Kidney Dis 1999; 33(1): 63\u201372.","journal-title":"Am J Kidney Dis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015254315839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015254315839\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015254315839.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:49:08Z","timestamp":1754891348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015254315839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["397674"],"URL":"https:\/\/doi.org\/10.1023\/a:1015254315839","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"type":"print","value":"0301-1623"},{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}